Dr. Anthony Fauci, the top disease official at the National Institutes of Health, said last week that work on a Zika vaccine had not been delayed, because his agency shifted funds from other areas amid the congressional inaction. He noted that other areas, however, such as research on cancer, heart disease and diabetes, had been hurt because research funds had to be shifted from them toward Zika.